CN1313118A - Hypoglycemic capsule - Google Patents
Hypoglycemic capsule Download PDFInfo
- Publication number
- CN1313118A CN1313118A CN 01106278 CN01106278A CN1313118A CN 1313118 A CN1313118 A CN 1313118A CN 01106278 CN01106278 CN 01106278 CN 01106278 A CN01106278 A CN 01106278A CN 1313118 A CN1313118 A CN 1313118A
- Authority
- CN
- China
- Prior art keywords
- restrains
- radix
- grams
- fructus
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A hypoglycemic capsule for treating diabetes is prepared from 19 Chinese-medicinal material including ginseng, cordyceps, astragalus root, schisandra fruit, anemarrhena rhizome, etc. Its advantages include durable saccharide-reducing action, high cure rate up to 80%, high total effective rate up to 98% and no toxic by-effect.
Description
The present invention relates to a kind of middle medicament for the treatment of diabetes.
The general effective percentage of medicament of existing treatment diabetes is about 70%, and cure rate is about 50%, and side effect is big, is prone to hypoglycemia, the damage kidney.
The objective of the invention is to develop a kind of cure rate height, the middle medicament capsules for diminishing diabetes and lowering sugar of the treatment diabetes that have no side effect.
For achieving the above object, medicine composition of the present invention comprises: Radix Ginseng 100 restrains, Cordyceps 50 restrains, the Radix Astragali 50 restrains, Fructus Schisandrae Chinensis 50 restrains, the Rhizoma Anemarrhenae 50 restrains, Fructus Corni 100 restrains, YANGHUOYE 100 restrains, Rhizoma Polygonati Odorati 50 restrains, the Rhizoma Atractylodis Macrocephalae 100 restrains, Radix Salviae Miltiorrhizae 100 restrains, Rhizoma Coptidis 50 restrains, Flos Lonicerae 50 restrains, Fructus Ligustri Lucidi 50 restrains, Cortex Mori 50 restrains, Cortex Phellodendri 50 restrains, Radix Puerariae 50 restrains, Gypsum Fibrosum 50 restrains, Fructus Lycii 100 restrains, the Radix Rehmanniae 50 restrains.
Concocting method: the Rhizoma Coptidis steeping in wine, the Fructus Corni enucleation mixes all each medicines then and sieves, and cleans, and dries, and is ground into foam together, and is encapsulated, every 0.5 gram.
Usage and dosage: oral every day three times, each three, 20 is a course of treatment.
Advantage of the present invention is: the treatment diabetes have lasting blood sugar lowering, glucose in urine effect, and cure rate is up to 80%, and total effective rate can reach 98%, and nontoxic, side effect.
Embodiment: get Radix Ginseng 100 grams, Cordyceps 50 grams, the Radix Astragali 50 grams, Fructus Schisandrae Chinensis 50 grams, the Rhizoma Anemarrhenae 50 grams, Fructus Corni 100 grams, YANGHUOYE 100 grams, Rhizoma Polygonati Odorati 50 grams, the Rhizoma Atractylodis Macrocephalae 100 grams, Radix Salviae Miltiorrhizae 100 grams, Rhizoma Coptidis 50 grams, Flos Lonicerae 50 grams, Fructus Ligustri Lucidi 50 grams, Cortex Mori 50 grams, Cortex Phellodendri 50 grams, Radix Puerariae 50 grams, Gypsum Fibrosum 50 grams, Fructus Lycii 100 grams, the Radix Rehmanniae 50 grams, the Rhizoma Coptidis steeping in wine, the Fructus Corni enucleation, then all each medicines are mixed and sieve, clean, dry, be ground into foam together, encapsulated, every 0.5 gram.
Claims (1)
1. capsules for diminishing diabetes and lowering sugar, be characterised in that its medicine composition comprises: Radix Ginseng 100 restrains, Cordyceps 50 restrains, the Radix Astragali 50 restrains, Fructus Schisandrae Chinensis 50 restrains, the Rhizoma Anemarrhenae 50 restrains, Fructus Corni 100 restrains, YANGHUOYE 100 restrains, Rhizoma Polygonati Odorati 50 restrains, the Rhizoma Atractylodis Macrocephalae 100 restrains, Radix Salviae Miltiorrhizae 100 restrains, Rhizoma Coptidis 50 restrains, Flos Lonicerae 50 restrains, Fructus Ligustri Lucidi 50 restrains, Cortex Mori 50 restrains, Cortex Phellodendri 50 restrains, Radix Puerariae 50 restrains, Gypsum Fibrosum 50 restrains, Fructus Lycii 100 restrains, the Radix Rehmanniae 50 restrains, and forms through the process of preparing Chinese medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01106278 CN1313118A (en) | 2001-03-07 | 2001-03-07 | Hypoglycemic capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01106278 CN1313118A (en) | 2001-03-07 | 2001-03-07 | Hypoglycemic capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1313118A true CN1313118A (en) | 2001-09-19 |
Family
ID=4655310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01106278 Pending CN1313118A (en) | 2001-03-07 | 2001-03-07 | Hypoglycemic capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1313118A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1965696B (en) * | 2005-11-15 | 2010-12-15 | 刘长现 | Health tea capable of lowering blood sugar |
| CN101708302B (en) * | 2009-12-08 | 2013-01-09 | 张为举 | Chinese medicinal preparation for treating diabetes and preparation method thereof |
| CN104432024A (en) * | 2014-11-04 | 2015-03-25 | 天津大学 | Traditional Chinese medicine composition having hypoglycemic effect |
-
2001
- 2001-03-07 CN CN 01106278 patent/CN1313118A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1965696B (en) * | 2005-11-15 | 2010-12-15 | 刘长现 | Health tea capable of lowering blood sugar |
| CN101708302B (en) * | 2009-12-08 | 2013-01-09 | 张为举 | Chinese medicinal preparation for treating diabetes and preparation method thereof |
| CN104432024A (en) * | 2014-11-04 | 2015-03-25 | 天津大学 | Traditional Chinese medicine composition having hypoglycemic effect |
| CN104432024B (en) * | 2014-11-04 | 2016-04-06 | 天津大学 | A kind of Chinese medicine composition with hypoglycemic activity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1951481A (en) | Medicament for treating cerebral thrombosis | |
| CN101856450B (en) | Chinese medicinal composition for treating diabetic nephropathy | |
| CN105031415A (en) | Prescription of traditional Chinese medicine capable of activating insulin for regulating hyperglycemia, as well preparation and application methods of traditional Chinese medicine | |
| CN102258710A (en) | Traditional Chinese medicine composition for treating type II diabetes | |
| CN101121001A (en) | New use of traditional Chinese medicines dendrobium, ophiopogon Japonicus, and trichosanthin for heat-clearing fire-draining and treating diabetes | |
| CN108042766A (en) | A kind of Bushen Tongluo supports brain cream and preparation method thereof | |
| CN101698056A (en) | Capsules for diminishing diabetes and lowering sugar | |
| CN104127823A (en) | Traditional Chinese medicine composition for treating infantile malnutrition and anorexia and preparation thereof | |
| CN112546148A (en) | Traditional Chinese medicine formula for treating chronic heart failure and preparation method thereof | |
| CN1305816A (en) | Medicine for treating diabetes | |
| CN1313118A (en) | Hypoglycemic capsule | |
| CN106309736B (en) | Anti-fatigue Chinese medicinal composition and its preparation method and application | |
| CN1365822A (en) | 'Shugan Lidan' capsule and its preparing process | |
| CN106109968A (en) | Rhizoma Gastrodiae, Radix Polygoni Multiflori Preparata pharmaceutical composition and preparation method thereof | |
| CN102755519B (en) | Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof | |
| CN102614404B (en) | Health product with auxiliary effect on reducing blood glucose and preparation method thereof | |
| CN105797034A (en) | Method for preparing traditional Chinese medicinal composition for treating steatohepatitis complicated with hyperlipidemia | |
| CN1292272A (en) | Medicine for curing diabetes and its preparation method | |
| CN102716359A (en) | Traditional Chinese patent medicine and traditional Chinese medicine decoction for effectively treating diarrhea | |
| CN1185959A (en) | Chinese medicine for chronic nephritis | |
| CN1141780A (en) | Human-body purifying agent | |
| CN111759999B (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for preventing and/or treating diabetes | |
| CN1389225A (en) | Diabetes treating Chinese medicine prepn. and its prepn. process | |
| CN106075103A (en) | Rhizoma Gastrodiae, Radix Polygoni Multiflori Preparata pharmaceutical composition and preparation technology thereof | |
| CN106075104A (en) | Rhizoma Gastrodiae, Radix Polygoni Multiflori Preparata combined pharmaceutical composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: WANG XINGCAI Free format text: FORMER OWNER: ZHANG SEN |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT INVENTOR; FROM: ZHANG SEN; TO: ZHANG SEN; WANG XINGCAI Effective date: 20010803 |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20010803 Address after: Taizi River Hospital, Liaoning, Liaoyang Zhang Senzhuan Applicant after: Wang Xingcai Inventor after: Zhang Sen Inventor after: Wang Xingcai Address before: Taizi River Hospital, Liaoning, Liaoyang Applicant before: Zhang Sen Inventor before: Zhang Sen |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |